| ACS | Acute coronary syndrome |
| ADMA | Asymmetric dimethyl arginine |
| AF | Atrial fibrillation |
| AIP | Atherogenic index of plasma |
| BMI | Body mass index |
| CAC | Coronary artery calcification |
| CARDIA | Coronary Artery Risk Development in Young Adults |
| CHD | Coronary heart disease |
| CI | Confidence interval |
| CIMT | Carotid intima-media thickness |
| CLMH | Cardiovascular–liver–metabolic health |
| CRP | C-reactive protein |
| CT | Computed tomography |
| CTCA | Computed tomography coronary angiography |
| CVD | Cardiovascular disease |
| E/A ratio | (EA) Early (E) to late atrial (A) transmitral flow velocity ratio |
| E/e′ ratio | Early transmitral flow velocity (E) to early diastolic mitral annular tissue velocity (e′) ratio |
| ECG | Electrocardiogram |
| FFA | Free fatty acids |
| FIB-4 | Fibrosis-4 score |
| FLI | Fatty liver index |
| GGT | Gamma-glutamyl transferase |
| HbA1c | Glycated hemoglobin |
| HDL | High-density lipoprotein |
| HF | Heart failure |
| HFpEF | Heart failure with preserved ejection fraction |
| HFrEF | Heart failure with reduced ejection fraction |
| HOMA-IR | Homeostatic Model Assessment for Insulin Resistance |
| HR | Hazard ratio |
| IL | Interleukin |
| LA | Left atrium/atrial |
| LDL | Low-density lipoprotein |
| LV | Left ventricle/ventricular |
| LVH | Left ventricular hypertrophy |
| MAFLD | Metabolic dysfunction-associated fatty liver disease |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MASH | Metabolic-associated steatohepatitis |
| MetALD | Metabolic and alcohol-related/associated liver disease |
| MI | Myocardial infarction |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| NFS | NAFLD fibrosis score |
| NLRP3 | NOD-like receptor family pyrin domain-containing protein 3 (inflammasome) |
| NO | Nitric oxide |
| OR | Odds ratio |
| OPERA | Oulu Project Elucidating Risk of Atherosclerosis |
| PNPLA3 | Patatin-like phospholipase domain-containing protein 3 |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 |
| PDE11A | Phosphodiesterase 11A |
| RR | Risk ratio |
| SMD | Standardized mean difference |
| T2DM | Type 2 diabetes mellitus |
| TLR | Toll-like receptor |
| TM6SF2 | Transmembrane 6 superfamily member 2 |
| TMEM98 | Transmembrane protein 98 |
| TMAO | Trimethylamine N-oxide |
| TYMS | Thymidylate synthase |
| VEGF | Vascular endothelial growth factor |